The Liverpool-based stem cell specialist raised the funds from founders, angels, and Spark Impact to scale manufacturing and run clinical trials.
"I am delighted to have secured our initial investment which will leverage our TSB grant. The investment will allow us to formally demonstrate our world-leading technology platform in a scientifically and clinically rigorous way, moving it further towards commercial reality. Sincere thanks to all of our investors for their support."
Business Growth Fund has provided growth capital split between ordinary shares and loan notes to back the footcare provider.
"Shuropody is a unique business which is already a market leader in its sector. It has the potential to substantially increase its geographic footprint across the UK with an active roll out programme that expects to generate up to 200 jobs. The business model is well placed for expansion into garden centre concessions and is already working with two of the largest garden centre operators in the UK."